Filter
788
Filtered Results: 788
Text search:
GAVI
Featured
Recommendations
77
New Publications
194
Language
Document type
No document type
338
Studies & Reports
184
Strategic & Response Plan
95
Guidelines
80
Manuals
38
Fact sheets
24
Situation Updates
12
Resource Platforms
8
Training Material
7
Infographics
2
Countries / Regions
Global
65
Colombia
30
Congo, Democratic Republic of
25
Liberia
21
Kenya
19
Sierra Leone
19
Africa
18
Burkina Faso
13
Latin America and the Carribbean
13
Myanmar / Burma
12
Nigeria
11
Ethiopia
11
Madagascar
11
Syria
10
Middle East and North Africa
10
Uganda
10
Nepal
9
Guinea
9
Brazil
9
Ghana
8
Germany
8
Western and Central Europe
8
East and Southern Africa
8
Malawi
7
Mozambique
7
South–East Asia Region
7
Benin
6
Rwanda
6
Peru
6
West and Central Africa
6
Bolivia
6
Bangladesh
6
South Africa
6
Central African Republic
6
Zambia
6
India
6
Cameroon
5
Senegal
5
South Sudan
5
Ukraine
4
Lesotho
4
Togo
4
Niger
4
Zimbabwe
4
Asia
4
Tanzania
4
Eastern Europe
4
Yemen
4
Ecuador
4
Pakistan
4
Cambodia
3
Eastern Europe and Central Asia
3
Argentina
3
Chile
2
Afghanistan
2
Haiti
2
Venezuela
2
France
2
Namibia
2
Sudan
2
Honduras
2
Mali
2
Angola
2
Indonesia
2
Somalia
2
Eswatini/ Swaziland
2
Guatemala
2
Timor Leste/ East Timor
1
Mexico
1
El Salvador
1
China
1
Congo-Brazzaville
1
Burundi
1
Philippines
1
USA
1
Guinea-Bissau
1
Saudi Arabia
1
Paraguay
1
Uruguay
1
Japan
1
United Kingdom
1
Spain
1
Côte d’Ivoire / Ivory Coast
1
Papua New Guinea
1
Nicaragua
1
Russia
1
Georgia
1
Chad
1
Iraq
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
299
Clinical Guidelines
64
Women & Child Health
52
Public Health
36
Key Resources
33
Capacity Building
8
Pharmacy & Technologies
7
Toolboxes
COVID-19
130
Health Financing Toolbox
59
TB
42
Rapid Response
40
AMR
36
Ebola & Marburg
31
Global Health Education
29
HIV
20
Planetary Health
18
Polio
17
Mental Health
15
Pharmacy
12
Cholera
10
Conflict
10
Refugee
8
NTDs
8
Natural Hazards
6
Disability
6
NCDs
6
Caregiver
5
Zika
1
Geneva, 22 May 2023 – Gavi, the Vaccine Alliance today published a roadmap* outlining critical actions needed to ensure supply of oral cholera vaccine (OCV) is able to meet growing demand from countries. Released against a backdrop of a recent wave of cholera outbreaks around the world, the roadma...
In April 2020, Gavi and COVAX joined the Access to COVID-19 Tools Accelerator (ACT-A) to provide equitable global access to COVID-19 vaccines to tackle the pandemic. In June 2020, the Gavi COVAX Advance Market Commitment (AMC) was launched to finance equitable access in 92 lower-income countries. Si...
Driving progress towards rabies elimination: Results of Gavi’s Learning Agenda on rabies and new WHO position on rabies immunization
The objectives of the meeting were to agree on coordinated and aligned support to the 3 countries’ national health recovery plans (Guinea, Liberia, Sierra Leone); to identify cross-cutting areas and opportunities for integration; to identify ways to improve implementation modalities; and to identi...
All vaccines work by exposing the body to molecules from the target pathogen to trigger an immune response – but the method of exposure varies. Here’s how DNA and RNA vaccines work.
the Principles for Dose-Sharing provide a framework for higher-income economies to make additional volumes secured via bilateral deals available through the Facility primarily to AMC participants, on an equitable basis. These principles outline that such doses must be safe and effective, available a...
Despite high regional demand for vaccines valued at over US$ 1 billion annually, Africa’s vaccine industry provides only 0.1% of global supply. Vaccine inequity and hoarding at the start of the pandemic, which resulted in delays in obtaining COVID-19 doses, stimulated new resolve to address future...
COVAX Initiative
recommended
COVAX is the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator
The ACT Accelerator is a ground-breaking global collaboration to accelerate the development, production, and equitable access to COVID-19 tests, treatments, and vaccines.
COVAX is co-led by Gavi, the Coalition for Epide...
Nursing Care Protocol for adult patients with COVID-19 without respiratory complications
Presentations and agenda of the meeting held to update industry on the COVAX Facility and Gavi’s support for cold chain equipment (CCE) for COVID-19 vaccines.
The UK government hosted the Global Vaccine Summit on June 4, 2020 under the patronage of the Rt. Hon. Boris Johnson, Prime Minister of the United Kingdom of Great Britain and Northern Ireland. The meeting was held by videoconference in light of the ongoing COVID-19 pandemic. 2. The Summit brought...
The Global Action Plan for Healthy Lives and Well-being for All (SDG3 GAP) is a set of commitments by 13 multilateral agencies to strengthen their collaboration. For this purpose several accelerators were created and an invitation for public comment was started. This document focuses on Accelerator ...
Six months after its launch on 24 April, the Access to COVID-19 Tools (ACT) Accelerator has already delivered concrete results in speeding up the development of new therapeutics, diagnostics, and vaccines. Now mid-way through the scale-up phase, the tools we need to fundamentally change the course o...
20 January 2021
In 2021 ACT-Accelerator will intensify its drive for equity and scale in the delivery of essential COVID-19 tools, while managing emerging viral risks. To address these major shifts and maintain momentum, ACT-Accelerator has defined four strategic priorities for 2021: Rapidly scale up the delivery o...
The Vaccination Demand Hub is a network of partner organizations innovating together to understand why people miss out and to improve acceptance and uptake of vaccines, to ensure that everyone everywhere is protected against vaccine preventable diseases.
BJPSYCH INTERNATIONALVOLUME 12NUMBER 4NOVEMBER 2015
The Ministry of Health is working with WHO, Gavi, MSF, UNICEF and other partners to ring vaccinate high-risk populations in Ebola-affected health zones in the Democratic Republic of the Congo. As vaccine supplies arrive in Geneva ahead of deployment to Kinshasa, WHO’s Dr Peter Salama explains what...
